QR код

Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors

Introduction: CD47 is a tumor antigen that inhibits phagocytosis leading to immune evasion. Anti-CD47 therapy is a promising new immunotherapy across numerous tumor types, but it has not been tested in thymic epithelial tumors (TETs): thymomas and thymic carcinomas. TETs are rare tumors that are dif...

Повний опис

Збережено в:
Автори: Thomas Yang Sun, MD, MHS, Brandon Nguyen, BA, Simon B. Chen, MD, Yasodha Natkunam, MD, PhD, Sukhmani Padda, MD, Matt van de Rijn, MD, Robert West, MD, PhD, Joel W. Neal, MD, PhD, Heather Wakelee, MD, Jonathan W. Riess, MD, MS
Формат: Artigo
Мова:Inglês
Опубліковано: Elsevier 2023-04-01
Серія:JTO Clinical and Research Reports
Предмети:
CD47
Thymoma
Thymic carcinoma
Immunotherapy
Thymic epithelial tumor
Онлайн доступ:http://www.sciencedirect.com/science/article/pii/S2666364323000371
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси